Publication | Closed Access
Budget Impact Analysis of Introducing Biosimilar Infliximab for the Treatment of Auto Immune Disorders In Five European Countries
10
Citations
0
References
2014
Year
RheumatologyTranslational MedicineAutoimmune DiseaseIntroducing Biosimilar InfliximabBudget Impact AnalysisImmunologyAutoimmunityImmunologic DiseaseAuto Immune DisordersInnovative TreatmentImmunotherapyMedicineTreatment Development
No additional data available for this publication yet. Check back later!